Daily Reporter

Today Don't Miss

Today Don't Miss

Are we reaching a turning point in metastatic prostate cancer?

At yesterday’s Presidential Symposium, a Late-Breaking Abstract presentation of the PROfound study reported a clinically meaningful benefit in radiological progression-free survival (PFS) with olaparib in men with BRCA1, BRCA2 or ATM mutations in metastatic castration-resistant…

Read More

The case of green tea extract discussed at ESMO 2019

With nutriceuticals regularly making headlines for their alleged benefits in the treatment or prevention of cancer, some clinicians are endeavouring to scientifically investigate claims and dispel fake news that can give false hope to patients….

Read More



Off-label therapies: what is their future?

Many studies presented at the Congress hint at promising treatments for rare sarcomas but access to effective treatments remains a challenge. Advances in cancer research and the regulatory approval of new agents do not usually…

Read More